Qube Research & Technologies LTD Heron Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

$62.3 Billion
Q2 2024

A detailed history of Qube Research & Technologies LTD transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 507,227 shares of HRTX stock, worth $1.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

507,227

Previous 561,984 9.74%

Holding current value

$1.02 Million

Previous $1.56 Million 14.07%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.32 - $3.86 $127,036 - $211,362	-54,757 Reduced 9.74%	507,227 $1.78 Million
Q1 2024 May 14, 2024	BUY	$1.71 - $3.06 $960,992 - $1.72 Million	561,984 New	561,984 $1.56 Million
Q3 2023 Nov 13, 2023	BUY	$0.97 - $1.8 $5,840 - $10,837	6,021 New	6,021 $6,000
Q4 2022 Feb 14, 2023	BUY	$2.25 - $4.67 $898,134 - $1.86 Million	399,171 Added 385.36%	502,756 $1.26 Million
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $64,606 - $130,426	24,288 Added 30.63%	103,585 $437,000
Q2 2022 Aug 15, 2022	BUY	$2.3 - $6.29 $5,096 - $13,938	2,216 Added 2.87%	79,297 $221,000
Q1 2022 May 09, 2022	BUY	$4.63 - $9.94 $356,885 - $766,185	77,081 New	77,081 $441,000
Q2 2020 Aug 14, 2020	SELL	$10.89 - $21.47 $125,703 - $247,828	-11,543 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$10.23 - $24.56 $58,178 - $139,672	-5,687 Reduced 33.01%	11,543 $136,000
Q4 2019 Feb 13, 2020	BUY	$17.42 - $26.61 $300,146 - $458,490	17,230 New	17,230 $405,000

Others Institutions Holding HRTX

# of Institutions

198

Shares Held

129M

Call Options Held

94.7K

Put Options Held

148K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $240M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Heron Therapeutics, Inc. Transaction History